Habig Scott Michael
SEC CIK 1938159 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Chief Commercial Off | 456.3K | $25.1K | $283.4K | 6 | 2022-11-09 | 2024-08-06 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Habig Scott Michael made no open-market trades at AUPH in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-08 | 2024-08-06 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.31 | -18.2K | 456.3K | -4% | -$96.9K | |
| 2024-03-07 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.60 | -17.8K | 474.6K | -4% | -$99.6K | |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.48 | -15.9K | 492.4K | -3% | -$87.0K | |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | A - Grant | $0.00 | +195.5K | 508.2K | +63% | $0 | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | A - Grant | — | +170.2K | 312.7K | +119% | — | |
| 2022-11-14 | 2022-11-09 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Off | P - Purchase | $5.02 | +5,000 | 5,000 | New | +$25.1K |
Purchase Sale Sale after option exercise All abbreviations